T1	Protein 50 53	CD2
T2	Protein 59 63	CD28
T3	Protein 185 188	CD2
T4	Protein 193 197	CD28
T5	Protein 288 301	interleukin 2
T6	Protein 303 307	IL-2
T7	Protein 390 394	IL-2
T8	Protein 465 490	IL-2 receptor alpha chain
T9	Protein 492 503	IL-2R alpha
T10	Protein 596 607	IL-2R alpha
T11	Protein 757 768	IL-2R alpha
T12	Protein 856 867	IL-2R alpha
T13	Protein 931 942	IL-2R alpha
T14	Protein 1008 1011	CD2
T15	Protein 1014 1018	CD28
T16	Protein 1073 1077	KBF1
T17	Protein 1078 1081	p50
T18	Protein 1177 1180	p50
T19	Protein 1181 1184	p65
T20	Protein 1210 1215	c-Rel
T21	Protein 1229 1234	c-Rel
T22	Protein 1235 1238	p65
T23	Protein 1397 1400	CD2
T24	Protein 1403 1407	CD28
T25	Protein 1749 1753	IL-2
T26	Protein 1765 1776	IL-2R alpha
T27	Protein 1959 1962	CD2
T28	Protein 1965 1969	CD28
T57	Exp 1626 1653	an oxygen radical scavenger
R7	Coref Anaphora:T36 Antecedent:T37
R8	Coref Anaphora:T38 Antecedent:T40
R9	Coref Anaphora:T49 Antecedent:T48
R10	Coref Anaphora:T53 Antecedent:T57
T35	Exp 276 307	This potent interleukin 2 (IL-2
T36	Exp 510 514	that
T37	Exp 451 509	the inducible IL-2 receptor alpha chain (IL-2R alpha) gene
T38	Exp 699 721	its consensus sequence
T39	Exp 636 656	the enhanced binding
T40	Exp 660 695	the transcription factor NF-kappa B
T41	Exp 725 730	the 5
T42	Exp 753 773	the IL-2R alpha gene
T43	Exp 874 876	we
T44	Exp 786 805	the molecular basis
T45	Exp 810 848	the unusually persistent transcription
T46	Exp 852 872	the IL-2R alpha gene
T47	Exp 989 1004	the time course
T48	Exp 1252 1276	Both inducible complexes
T49	Exp 1309 1330	Their relative levels
T50	Exp 1353 1365	the duration
T51	Exp 1484 1488	that
T52	Exp 1521 1542	the signaling pathway
T53	Exp 1654 1658	that
T54	Exp 1679 1701	the nuclear appearance
T55	Exp 1860 1864	that
T56	Exp 1838 1851	these results
